Medscape

Drug Slows Progression of Primary Sclerosing Cholangitis

AMSTERDAM — Norucholic acid (NCA), an investigational therapy, demonstrated significant superiority over placebo in halting disease progression in patients with primary sclerosing cholangitis (PSC), ...
Morningstar

Chemomab Announces New Patent Awards for Its First-in-Class Agent Nebokitug that is Positioned to Potentially Become the First Approved Drug for Primary Sclerosing Cholangitis

—New Patents Covering Use of Nebokitug for the Treatment of Liver Diseases including Primary Sclerosing Cholangitis Issued in China and Russia Providing Coverage Up To 2041— —Further Expands ...
Morningstar

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of ...
Nasdaq

Chemomab Reports Positive Phase 2 Data For Nebokitug In Primary Sclerosing Cholangitis

(RTTNews) - Chemomab Therapeutics, Ltd. (CMMB) Thursday reported positive results from the open-label extension (OLE) portion of the Phase 2 SPRING study evaluating nebokitug as a treatment for ...
Nasdaq

Esperion Expands Development Portfolio with Innovative Allosteric ACLY Inhibitor Program Targeting Primary Sclerosing Cholangitis

Esperion announced the expansion of its development portfolio with a new program aimed at treating primary sclerosing cholangitis (PSC), a rare liver disease. The company confirmed the effectiveness ...
Hosted on MSN

Family issue sad Russell Hoult update as Derby County hero battles cancer amid fundraising bid

Former Derby County goalkeeper Russell Hoult is receiving palliative care amid an ongoing battle with cancer. Hoult was diagnosed with Primary Sclerosing Cholangitis in 2023 and in August last year ...